What is the recommended diet and supplementation for individuals with MTHFR (Methylenetetrahydrofolate Reductase) C677T homozygous mutation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Diet and Supplementation for MTHFR C677T Homozygous Mutation

For individuals with MTHFR C677T homozygous mutation, supplementation with 5-methyltetrahydrofolate (5-MTHF) is strongly recommended over standard folic acid, along with vitamin B12 (methylcobalamin), vitamin B6, and riboflavin to effectively reduce homocysteine levels and associated cardiovascular risks. 1

Understanding MTHFR C677T Homozygosity

  • MTHFR (Methylenetetrahydrofolate Reductase) is an enzyme that converts folate to its active form (5-methyltetrahydrofolate) in the homocysteine metabolism pathway 1
  • The C677T homozygous mutation (TT genotype) significantly reduces enzyme activity, leading to impaired folate metabolism and potential hyperhomocysteinemia 2
  • Homozygosity for this mutation occurs in approximately 10-15% of the general population, with higher prevalence in certain ethnic groups (23.6% in Chinese populations) 2
  • Elevated homocysteine is associated with a 2-3 fold increased risk for atherosclerotic vascular disease, including stroke 2

Recommended Supplementation Strategy

Primary Supplements:

  • 5-Methyltetrahydrofolate (5-MTHF): 5mg daily is preferred over standard folic acid as it bypasses the defective MTHFR enzyme 1, 3

    • This active form can reduce homocysteine levels by 25-30% in individuals with the TT genotype 1
    • Standard folic acid requires conversion by the deficient MTHFR enzyme, making it less effective 2
  • Vitamin B12: 1mg weekly (as methylcobalamin or hydroxycobalamin, not cyanocobalamin) 2, 3

    • Adding B12 provides an additional 7% reduction in homocysteine levels 1
    • TT homozygotes respond better with both folate and B12 levels above median values 2
  • Vitamin B6: 50mg daily to support the transsulfuration pathway of homocysteine metabolism 3, 2

  • Riboflavin: Supplementation appears particularly effective for individuals with the TT genotype 4, 2

Dietary Recommendations

  • Focus on foods naturally rich in folate rather than those fortified with folic acid 2

    • Leafy greens, legumes, fruits, and vegetables provide natural folates
    • Avoid excessive consumption of folic acid-fortified foods
  • Ensure adequate intake of vitamin B12 through animal products or supplements if vegetarian/vegan 5

  • Include riboflavin-rich foods (dairy, eggs, lean meats, green vegetables) 4

Monitoring and Follow-up

  • Measure plasma homocysteine levels before and after initiating supplementation 1

    • Target reduction to normal range (<15 μmol/L) 6
    • Supplementation can reduce homocysteine from elevated levels (19.4±5.3μmol/L) to normal range (6.9±2.2μmol/L) 3
  • Consider periodic assessment of serum folate and B12 levels 7

    • Individuals with TT genotype typically show lower serum folate response to supplementation (7.2 nmol/L vs. 8.7 nmol/L in CC genotype) 7

Special Considerations

  • The combination of methylfolate, B6, and B12 has shown beneficial effects in various clinical contexts beyond cardiovascular risk 3

  • Individuals with MTHFR mutations who are prescribed methotrexate should receive appropriate folate supplementation to reduce side effects 1

  • While elevated homocysteine is associated with increased cardiovascular risk, treatment should be tailored based on both homocysteine levels and MTHFR genotype 1

Common Pitfalls to Avoid

  • Using standard folic acid instead of 5-MTHF in individuals with TT genotype 2
  • Using cyanocobalamin instead of methylcobalamin or hydroxycobalamin 2
  • Failing to include riboflavin, which is particularly important for TT homozygotes 4
  • Overlooking the need for comprehensive B vitamin supplementation rather than focusing solely on folate 2

References

Guideline

MTHFR Mutation Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

B-vitamins, homocysteine metabolism and CVD.

The Proceedings of the Nutrition Society, 2004

Research

Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.